​

Funding Round

Series B - Pulmatrix

Series B - Pulmatrix

Investment Firm

Overview

Pulmatrix develops inhaled therapies for the treatment, prevention and transmission of infectious and progressive respiratory diseases.

Announced Date

Aug 15, 2011

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

4

Investor Name
Participant Investor5AM Ventures
Participant InvestorNovartis Venture Fund
Participant InvestorARCH Venture Partners
Participant InvestorPolaris Partners

Round Details and Background

Pulmatrix raised $14000000 on 2011-08-15 in Series B

Pulmatrix develops inhaled therapies for the treatment, prevention and transmission of infectious and progressive respiratory diseases.

Company Funding History

10

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Aug 15, 2011
Series B - Pulmatrix
4-14.0M
Dec 14, 2010
Grant - Pulmatrix
-5.7M
Mar 11, 2009
Series A - Pulmatrix
2-3.5M
Nov 02, 2009
Series B - Pulmatrix
4-30.2M

Recent Activity

There is no recent news or activity for this profile.